INSUBCONTINENT EXCLUSIVE:
The pharmaceutical industry in the United States is under the regulatory gun to bolster its ability to accurately track and trace the
drugs it manufactures and ships to store shelves and healthcare facilities.Those regulations include tracking medications that are returned
by stores and healthcare facilities for resale.Currently, the industry uses a patchwork of central databases based on the Electronic Data
Interchange (EDI) standard that features point-to-point connections between manufacturer and distributor; that system is costly and makes
large-scale interoperability almost impossible
The central database approach is also open the risk of diversion, counterfeit and a trust gap between siloed systems.
